CD4 and neoplasm: Interestingly, inhibition of the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) activity in Tregs induces Treg-mediated pro-inflammatory functions, enhancing IFNγ production by CD8+ and CD4+ Th1 cells and anti-tumor immune responses [131].